DK0661998T3 - Terapeutisk middel fra mycobacterium vaccae og dets anvendelse imod HIV-infektion med AIDS - Google Patents

Terapeutisk middel fra mycobacterium vaccae og dets anvendelse imod HIV-infektion med AIDS

Info

Publication number
DK0661998T3
DK0661998T3 DK93905520T DK93905520T DK0661998T3 DK 0661998 T3 DK0661998 T3 DK 0661998T3 DK 93905520 T DK93905520 T DK 93905520T DK 93905520 T DK93905520 T DK 93905520T DK 0661998 T3 DK0661998 T3 DK 0661998T3
Authority
DK
Denmark
Prior art keywords
aids
therapeutic agent
hiv infection
against hiv
use against
Prior art date
Application number
DK93905520T
Other languages
Danish (da)
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Stanford Rook Ltd
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd, Univ London filed Critical Stanford Rook Ltd
Application granted granted Critical
Publication of DK0661998T3 publication Critical patent/DK0661998T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93905520T 1992-09-14 1993-03-05 Terapeutisk middel fra mycobacterium vaccae og dets anvendelse imod HIV-infektion med AIDS DK0661998T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use
PCT/GB1993/000463 WO1994006466A1 (en) 1992-09-14 1993-03-05 Therapeutic agent from mycobacterium vaccae and its use against hiv infection

Publications (1)

Publication Number Publication Date
DK0661998T3 true DK0661998T3 (da) 1999-08-09

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93905520T DK0661998T3 (da) 1992-09-14 1993-03-05 Terapeutisk middel fra mycobacterium vaccae og dets anvendelse imod HIV-infektion med AIDS

Country Status (17)

Country Link
EP (1) EP0661998B1 (de)
JP (1) JPH06100457A (de)
KR (1) KR100272743B1 (de)
CN (1) CN1060937C (de)
AP (1) AP510A (de)
AT (1) ATE173633T1 (de)
AU (1) AU683835B2 (de)
BR (1) BR9303762A (de)
CA (1) CA2105646A1 (de)
DE (1) DE69322280T2 (de)
DK (1) DK0661998T3 (de)
ES (1) ES2125331T3 (de)
GB (1) GB9219425D0 (de)
RU (1) RU2106878C1 (de)
SG (1) SG72610A1 (de)
WO (1) WO1994006466A1 (de)
ZA (1) ZA935575B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU730548B2 (en) * 1996-12-18 2001-03-08 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the TH2 activity of the immune system
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
CA2472481A1 (en) * 2001-01-17 2002-07-25 Bakulesh Mafatlal Khamar Use of mycobacterium w for the treatment of human immunodeficiency virus (hiv) disease infection
WO2002056898A2 (en) * 2001-01-17 2002-07-25 Mafatlal Khamar Bakulesh Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
CA2474794A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv Indravadan Method of providing prophylaxis for tuberculosis in hiv positive individuals
KR20050008452A (ko) * 2002-03-08 2005-01-21 바쿠레시 마파탈 카마르 결핵의 치료방법
RU2380114C1 (ru) * 2008-06-25 2010-01-27 Людмила Анатольевна Шовкун Способ лечения туберкулеза легких у больных вич-инфекцией
JP7760151B2 (ja) * 2021-09-09 2025-10-27 国立大学法人東京海洋大学 抗酸菌症用ｄｎａワクチン及びそれを用いた抗酸菌症の予防方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use

Also Published As

Publication number Publication date
AU3642093A (en) 1994-04-12
GB9219425D0 (en) 1992-10-28
ES2125331T3 (es) 1999-03-01
HK1011289A1 (en) 1999-07-09
SG72610A1 (en) 2001-07-24
JPH06100457A (ja) 1994-04-12
CN1089478A (zh) 1994-07-20
RU2106878C1 (ru) 1998-03-20
ATE173633T1 (de) 1998-12-15
DE69322280T2 (de) 1999-04-22
ZA935575B (en) 1994-03-01
KR950703360A (ko) 1995-09-20
DE69322280D1 (de) 1999-01-07
WO1994006466A1 (en) 1994-03-31
CA2105646A1 (en) 1994-03-15
AP9300555A0 (en) 1993-10-31
CN1060937C (zh) 2001-01-24
KR100272743B1 (ko) 2000-11-15
EP0661998A1 (de) 1995-07-12
EP0661998B1 (de) 1998-11-25
AU683835B2 (en) 1997-11-27
AP510A (en) 1996-07-23
BR9303762A (pt) 1994-03-22

Similar Documents

Publication Publication Date Title
DK0661998T3 (da) Terapeutisk middel fra mycobacterium vaccae og dets anvendelse imod HIV-infektion med AIDS
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
NO963508D0 (no) Ureasebasert vaksine og behandling av Heliobacter infeksjon
DK0629347T3 (da) Antibakterielt middel og behandling af genstande dermed
FI955509L (fi) HIV-tartunnan ja AIDSin ribotsyymigeeniterapia
DK316988D0 (da) Transdermalt farmaceutisk praeparat og dets anvendelse
AU6816194A (en) Methods and materials for treatment of individuals infected with intracellular infectious agents
HUP9902055A3 (en) Medical composition for the treatment of herpes simplex virus and other infectious diseases
DE3669997D1 (de) Rollstuhl und anwendungsweise.
DK132689D0 (da) Oralt antitandstensmiddel og dets anvendelse
DK0588878T3 (da) Universal, vandbaseret medicinsk cement og dentalcement
PL297849A1 (en) Vaccine against and method of treating the patients infectedwith hiv virus
ZA90245B (en) Treatment of diseases associated with hiv infections
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
DK139393D0 (da) Laegetermometer med digitalt og talende display
DE69123958D1 (de) Wegwerfwerkzeug und -einsatz
NO922531D0 (no) Middel for forhindring av og behandling av fiskesykdommer
DK428189D0 (da) Brandhaemmende middel og dets anvendelse
PL317876A1 (en) Combined treatment of hiv infections
EP0490250A3 (en) Use of interferon and an antimalarial agent for the treatment of malarial infections
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
NO932315D0 (no) Overflateaktivt middel, fremgangsmaate ved dets fremstilling og anvendelse
DK365489A (da) Fremgangsmaade til diagnostisering af hiv-infektion og diagnostiseringsapparat til anvendelse ved fremgangsmaaden
DK554887D0 (da) Terapeutisk middel samt dets anvendelse
DK621687A (da) Middel med rensende og hudplejende egenskaber